mifepristone has been researched along with Depression, Endogenous in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, H; Liu, D; Liu, Y; Pan, F; Wang, R; Xu, J | 1 |
| Li, YY; Liu, BP; Liu, FM; Peng, ZL; Song, C; Wang, HY; Zhang, C; Zhang, YP | 1 |
| Jiang, H; Liu, D; Liu, Y; Pan, F; Wang, R; Wang, W; Xu, J | 1 |
| Belanoff, JK; Blasey, CM; Block, TS; Roe, RL | 1 |
| Charney, DS; Drevets, WC; Gold, PW | 1 |
| Song, C | 1 |
| Nemeroff, CB | 1 |
| Schatzberg, AF | 1 |
| Rothschild, AJ | 1 |
| Craft, TK; DeVries, AC | 1 |
| Carroll, BJ; Rubin, RT | 1 |
| Benton, T; Douglas, SD; Dubé, B; Evans, DL; Gettes, DR; Lai, JP; Lynch, KG; Metzger, D; Tustin, NB | 1 |
| Filipini, D; Ghadirian, AM; Murphy, BE | 1 |
| Murphy, BE | 1 |
| Belanoff, J; Chu, JW; Feldman, D; Hoffman, AR; Matthias, DF; Schatzberg, A | 1 |
| Carroll, BJ; Krishnan, KR; Nemeroff, CB; Reed, D; Ritchie, JC; Saunders, WB; Wilson, WH | 1 |
| Brandt, HA; Calabrese, JR; Chrousos, GP; Demitrack, MA; Geracioti, TD; Gold, PW; Kalogeras, K; Kling, MA; Perini, GI; Whitfield, HJ | 1 |
| Sikes, CR; Stokes, PE | 2 |
| Allilaire, JF; Ammar, S; Baulieu, EE; Lecrubier, Y; Widlocher, D | 1 |
6 review(s) available for mifepristone and Depression, Endogenous
| Article | Year |
|---|---|
The effect of thymectomy and IL-1 on memory: implications for the relationship between immunity and depression.
Topics: Animals; Corticosterone; Cytokines; Depressive Disorder; Disease Models, Animal; Dopamine; Hormone Antagonists; Interleukin-1; Limbic System; Lymphocytes; Macrophages; Memory Disorders; Mifepristone; Norepinephrine; Rats; Receptors, Glucocorticoid; Serotonin; Thymectomy; Thymus Gland | 2002 |
New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
Topics: Animals; Antidepressive Agents; Brain; Corticotropin-Releasing Hormone; Depressive Disorder; Hormone Antagonists; Humans; Mifepristone; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid | 2002 |
New approaches to managing psychotic depression.
Topics: Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Electroconvulsive Therapy; Fluoxetine; Humans; Lithium; Mifepristone; Olanzapine; Pirenzepine; Receptors, Glucocorticoid; Treatment Outcome | 2003 |
Antiglucocorticoid therapies in major depression: a review.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Dexamethasone; Glucocorticoids; Hormone Antagonists; Humans; Mifepristone | 1997 |
The hypothalamic-pituitary-adrenocortical axis in major depression.
Topics: Adrenocorticotropic Hormone; Body Fluids; Corticotropin-Releasing Hormone; Depressive Disorder; Estrenes; Humans; Hypothalamo-Hypophyseal System; Metyrapone; Mifepristone; Physostigmine; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Vasopressins | 1988 |
The hypothalamic-pituitary-adrenocortical axis in major depression.
Topics: Adrenocorticotropic Hormone; Brain; Corticotropin-Releasing Hormone; Depressive Disorder; Estrenes; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Metyrapone; Mifepristone; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Receptors, Glucocorticoid; Saliva | 1988 |
4 trial(s) available for mifepristone and Depression, Endogenous
| Article | Year |
|---|---|
Efficacy and safety of mifepristone for the treatment of psychotic depression.
Topics: Adult; Depressive Disorder; Dizziness; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Mifepristone; Psychotic Disorders; Treatment Outcome | 2011 |
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Biphenyl Compounds; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Glucocorticoids; HIV Seropositivity; Hormone Antagonists; Humans; Immunity, Innate; Killer Cells, Natural; Lymphocyte Count; Middle Aged; Mifepristone; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Substance P; T-Lymphocytes, Cytotoxic; Viral Load | 2008 |
Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.
Topics: Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone; Personality Inventory; Receptors, Glucocorticoid | 1993 |
Effects of glucocorticoid antagonism with RU 486 on pituitary-adrenal function in patients with major depression: time-dependent enhancement of plasma ACTH secretion.
Topics: Adrenocorticotropic Hormone; Adult; Depressive Disorder; Female; Glucocorticoids; Humans; Male; Mifepristone; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Time Factors | 1989 |
10 other study(ies) available for mifepristone and Depression, Endogenous
| Article | Year |
|---|---|
FKBP5 and specific microRNAs via glucocorticoid receptor in the basolateral amygdala involved in the susceptibility to depressive disorder in early adolescent stressed rats.
Topics: Age Factors; Animals; Basolateral Nuclear Complex; Behavior, Animal; Depressive Disorder; Dexamethasone; Disease Models, Animal; Disease Susceptibility; Glucocorticoids; Hormone Antagonists; Male; Memory Disorders; MicroRNAs; Mifepristone; Rats; Rats, Wistar; Receptors, Glucocorticoid; Stress, Psychological; Tacrolimus Binding Proteins | 2017 |
Mifepristone attenuates depression-like changes induced by chronic central administration of interleukin-1β in rats.
Topics: Amygdala; Anhedonia; Animals; Antidepressive Agents; Corticosterone; Depressive Disorder; Disease Models, Animal; Hormone Antagonists; Interleukin-1beta; Male; Mifepristone; Motor Activity; Nerve Growth Factors; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Recombinant Proteins; RNA, Messenger | 2018 |
Short- and long-term alterations of FKBP5-GR and specific microRNAs in the prefrontal cortex and hippocampus of male rats induced by adolescent stress contribute to depression susceptibility.
Topics: Age Factors; Animals; Brain; Depression; Depressive Disorder; Disease Susceptibility; Glucocorticoids; Hippocampus; Hypothalamo-Hypophyseal System; Male; MicroRNAs; Mifepristone; Pituitary-Adrenal System; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Glucocorticoid; Stress, Psychological; Tacrolimus Binding Proteins | 2019 |
New insights into the role of cortisol and the glucocorticoid receptor in severe depression.
Topics: Amygdala; Antidepressive Agents; Depressive Disorder; Hippocampus; Humans; Hydrocortisone; Hypothalamus; Mifepristone; Prefrontal Cortex; Receptors, Glucocorticoid | 2002 |
Conflict-of-interest charge.
Topics: Affective Disorders, Psychotic; Book Reviews as Topic; Conflict of Interest; Depressive Disorder; Disclosure; Humans; Mifepristone; Scientific Misconduct; Treatment Outcome | 2004 |
Role of IL-1 in poststroke depressive-like behavior in mice.
Topics: Animals; Antimetabolites; Depressive Disorder; Drinking Behavior; Glucocorticoids; Hormone Antagonists; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Interleukin-1; Male; Metyrapone; Mice; Mice, Inbred C57BL; Mifepristone; Receptors, Glucocorticoid; Receptors, Interleukin-1; Stroke; Sucrose | 2006 |
Is mifepristone useful in psychotic depression?
Topics: Adrenocorticotropic Hormone; Affective Disorders, Psychotic; Antidepressive Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Depressive Disorder; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mifepristone; Patient Selection; Receptors, Glucocorticoid; Reproducibility of Results; Treatment Outcome | 2006 |
Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).
Topics: Adrenocorticotropic Hormone; Black or African American; Bone Density; Brain; California; Cholesterol; Cushing Syndrome; Depressive Disorder; Glycated Hemoglobin; Heart Failure; Hormone Antagonists; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Mifepristone; Osteocalcin; Ventricular Function, Left | 2001 |
RU486 in depression.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Antidepressive Agents; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone | 1992 |
Afternoon increase in plasma cortisol in depressed patients receiving an antiglucocorticosteroid in the morning.
Topics: Adult; Circadian Rhythm; Depressive Disorder; Estrenes; Glucocorticoids; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone | 1986 |